(Q54573044)

1 June 2018

title

Differential gene expression between human schwannoma and control Schwann cells. (English)

1 reference

1 June 2018

0 references

1

1 reference

1 June 2018

author name string

Bartelt-Kirbach B

2

1 reference

1 June 2018

Diebold R

3

1 reference

1 June 2018

Kämpchen K

4

1 reference

1 June 2018

Langmesser S

5

1 reference

1 June 2018

Utermark T

6

1 reference

1 June 2018

publication date

1 December 2006

1 reference

1 June 2018

Neuropathology and Applied Neurobiology

published in

1 reference

1 June 2018

volume

32

1 reference

1 June 2018

issue

6

1 reference

1 June 2018

page(s)

605-614

1 reference

1 June 2018

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Neurofibroma and schwannoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

The neurofibromatoses: when less is more

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

NF2deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Neurofibromatosis 2 (NF2) tumor suppressor schwannomin and its interacting protein HRS regulate STAT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Merlin, the Product of the Nf2 Tumor Suppressor Gene, Is an Inhibitor of the p21-Activated Kinase, Pak1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Merlin neutralizes the inhibitory effect of Mdm2 on p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Rearrangements of the intermediate filament GFAP in primary human schwannoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Selective expression of prion protein in peripheral tissues of the adult mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Prion protein prevents human breast carcinoma cell line from tumor necrosis factor alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Insulin-like growth factors and neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Insulin-like growth factor binding protein (IGFBP) signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

The IGF/IGFBP system in CNS malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Characterization of the tyrosine kinase Tnk1 and its binding with phospholipase C-gamma1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Insulin-like growth factors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Association between Components of the Insulin-Like Growth Factor System and Endometrial Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

Association between Components of the Insulin-Like Growth Factor System and Epithelial Ovarian Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2006.00769.X

10.1111/J.1365-2990.2006.00769.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018